Who owns COLUMN GROUP L P?

No ownership or control links for COLUMN GROUP L P are resolved in the current sources yet â€” view the network graph to expand, or pull the cited JSON dossier.

What is COLUMN GROUP L P's risk level?

WhiteIntel flags COLUMN GROUP L P as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does COLUMN GROUP L P appear across sources?

COLUMN GROUP L P is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE Â· CORPUS

SnitchScore · reading…

evidence coverage · reading…

Legal entityLow

COLUMN GROUP L P

Name: COLUMN GROUP L P — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, COLUMN GROUP L P, Company, US

COLUMN GROUP L P — US company (sec:0001347769). 5 holdings. Every claim linked to its source.

SEC 0001347769CompanyUS

Ownership graph Export .md

JSON / MCPsample

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

Holdings / subsidiaries

COLUMN GROUP L P
- NGM BIOPHARMACEUTICALS INC· director· via SEC EDGAR
- Nurix Therapeutics, Inc.· tenpercentowner· via SEC EDGAR
- CONSTELLATION PHARMACEUTICALS INC· tenpercentowner· via SEC EDGAR
- IMMUNE DESIGN CORP.· tenpercentowner· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for COLUMN GROUP L P — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

/02

People & control

4 parties Â· 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
CONSTELLATION PHARMACEUTICALS INC
Also holds roles at 80 other companies
- HUMPHREY JEFFREYofficer
- RAYTHATHA JIGARofficer
- RAYTHATHA JIGARdirector
●
IMMUNE DESIGN CORP.
Also holds roles at 53 other companies
- GOMBOTZ WAYNEofficer
- COLUMN GROUP II, LPtenpercentowner
- PONOI CAPITAL, LPtenpercentowner
●
NGM BIOPHARMACEUTICALS INC
Also holds roles at 57 other companies
- GOEDDEL DAVID Vdirector
- PONOI II MANAGEMENT, LLCtenpercentowner
- PONOI MANAGEMENT, LLCtenpercentowner
●
Nurix Therapeutics, Inc.
Also holds roles at 47 other companies
- Baynes Roy D.director
- van Houte Hansofficer
- SANDS ARTHUR Tofficer

4 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns COLUMN GROUP L P?: No ownership or control links for COLUMN GROUP L P are resolved in the current sources yet â€” view the network graph to expand, or pull the cited JSON dossier.
What is COLUMN GROUP L P's risk level?: WhiteIntel flags COLUMN GROUP L P as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does COLUMN GROUP L P appear across sources?: COLUMN GROUP L P is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.